Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

Newest OICR Investigator seeks to develop precision treatments for young people with high risk leukemia

Precision magnetics could be game-changer for therapy-resistant brain cancers

Zooming in on mouse brain development reveals origins of human glial cancers

Breaking through the blood-tumour barrier to better treat brain cancer